title: [Ophthalmologic prevention of chloroquine and hydroxychloroquine induced retinopathy].
abstract: BACKGROUND
  Antimalarial drugs induce severe retinal toxicity. The aims of this study were to evaluate the strategy of screening clinical and preclinical intoxication due to antimalarial agents in two centres of reference and to describe the results of ophthalmologic examination.
  
  
  METHODS
  Patients referred for ophthalmologic evaluation in connection with antimalarial agents therapy in the Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts from October 1999 to December 2000 and in the Hôpital Lariboisière from January 1995 to December 1998 were investigated. A retrospective review of results of ophthalmologic examination, electroretinogram, electro-oculogram, colour vision test and central visual field was conducted to assess retinal intoxication.
  
  
  RESULTS
  Among 705 patients recruited in the Centre des Quinze-Vingts, 10 out of 133 who were never treated had an electrophysiological contra-indication to the treatment. Among the 572 other patients, 31 presented with preclinical intoxication (5.4 p. 100) and 8 other patients presented with clinical intoxication. Among 925 patients recruited in the Hôpital Lariboisière, 37 presented with preclinical intoxication (4 p. 100) and four patients presented with clinical intoxication.
  
  
  CONCLUSIONS
  The antimalarial drugs clinical intoxication is rare but nevertheless real. Screening for preclinical intoxication can prevent the evolution toward irreversible retinal intoxication. Diagnosis of preclinical intoxication is established through the confrontation of results of different tests and their evolution. The multifocal electroretinogram remains to be evaluated.
  
  
  CONCLUSIONS
  Ophthalmologic monitoring including funduscopy, should be recommended at least once a year. Visual field seems to become interesting in the screening. Electroretinogram and electro-oculogram remain useful quantitative and obvious tests. A prospective study to assess the optimal way to prevent retinal intoxication is mandatory.
authors.affiliation: Laboratoire de Physiologie de la Perception et de l'Action, Collège de France, Paris.
authors.forename: E
authors.initials: E
authors.lastname: Bui Quoc
authors.forename: I
authors.initials: I
authors.lastname: Ingster-Moati
authors.forename: M-H
authors.initials: MH
authors.lastname: Rigolet
authors.forename: O
authors.initials: O
authors.lastname: Chosidow
authors.forename: B
authors.initials: B
authors.lastname: Bodaghi
mesh_terms: D000962:Antimalarials / Q000009:adverse effects*; D002738:Chloroquine / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006886:Hydroxychloroquine / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D012164:Retinal Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000517:prevention & control*; D012189:Retrospective Studies
chemical_list: D000962:Antimalarials; D006886:Hydroxychloroquine; D002738:Chloroquine